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Microsporidia are now recognized as important pathogens of AIDS patients; the
ability of  these parasites to cause disease in immunocompetent persons is still being
elucidated.  Improved diagnostic tests for microsporidial infection are continually being
sought for establishing diagnosis in order to avoid laborious electron microscopy studies
that require invasively acquired biopsy specimens.  Modified trichrome or chemofluorescent
stains are useful for detecting microsporidia in bodily fluids and stool specimens, but
they do not allow for speciation of microsporidia.  Polymerase chain reaction with
specific primers will allow the detection and speciation of microsporidia in biopsy tissue,
bodily fluids, and stool specimens.
ods for microsporidia infection, though continually
being  improved, have shortcomings that molecular
diagnostic techniques may be able to overcome.
Biologic Properties of Microsporidia
Microsporidia are obligate intracellular parasites
that infect most invertebrates and all classes of ver-
tebrates.  They belong to the phylum Microspora in
the subkingdom Protozoa.  They are considered an-
cient eukaryotes that multiply by binary fission and
have a membrane bound nucleus; they lack mito-
chondria and Golgi membranes (5).  In addition to
causing disease in humans, these parasites cause
disease in insects, mammals, and fish; therefore,
they may create economic headaches for industries
such as fisheries and silk production.  They may also
be beneficial to humans as biologic control agents
for such pests as grasshoppers and locusts (5).
In host cells, microsporidia replicate either in a
parasitophorous vacuole, like the members of the
genus Encephalitozoon, or directly in the cytoplasm
like E. bieneusi.  Vegetative and spore stages of the
organisms can be found in the host cell as the para-
site undergoes merogony and sporogony, resulting
in the production of the infective spore stage of the
parasite (7)  (Figure 1).  The spores of microsporidia
contain the uniquely characteristic coiled polar tu-
bule (Figure 2). Under  appropriate conditions within
a suitable host, the polar tubule of the spore is ex-
truded (Figures 3 and 4).  Contact of the end of the
tubule with a host cell membrane allows the spore
to transfer its contents (sporoplasm) to initiate in-
fection within the new host cell.  An influx of calcium
into the spore coincides with the extrusion of the
polar tubule, and this mechanism may provide a
target for therapy for microsporidiosis since calcium
Microsporidiosis is truly an emerging infectious
disease. Although microsporidia were discovered
more than 100 years ago (1), the first well-docu-
mented case of human microsporidiosis was not
reported until 1959 (2). Human microsporid-
iosis remained an uncommon infection until the
human immunodeficiency virus (HIV) pandemic; the
first cases of microsporidial infection in HIV-infected
patients were reported in 1985 (3,4).  Since then,
more than 400 HIV-associated microsporidial infec-
tions have been reported, which indicates that
microsporidia are common opportunistic pathogens
in patients with AIDS (5). Infections caused by
three new species,  Enterocytozoon bieneusi,
Encephalitozoon intestinalis, and E. hellem, have
been described in patients with acquired immuno-
deficiency syndrome (AIDS). Originally thought to
be an opportunistic pathogen of AIDS patients ex-
clusively, E. bieneusi was reported in 1994 to be the
cause of acute, self-limited traveler’s diarrhea in an
immunocompetent person who was not infected with
HIV (6).
As microsporidia have been increasingly recog-
nized as pathogens of both immunosuppressed and
immunocompetent persons, the need for rapid and
specific diagnosis of microsporidial infection has
arisen.  For instance, albendazole therapy can cure
E. intestinalis infections but is reported to be of little
benefit to patients infected with E. bieneusi (5);
therefore, identifying microsporidia to species level
could have important implications in the clinical
management of patients.  Current diagnostic meth-
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target for therapy for microsporidiosis since calcium
channel blockers have been shown to inhibit extru-
sion and the infection of host cells in vitro (8).
The human microsporidial pathogens and their
clinical manifestations are shown in Table 1.  The
most common microsporidial disease is prolonged
diarrhea with wasting caused by E. bieneusi or E.
intestinalis in AIDS patients with CD4 T-cell counts
below 50 cells/ul.  Microsporidia have been reported
in up to 39% of  AIDS patients with diarrhea (9).
Microsporidia may disseminate to cause systemic
infection (Table 1); these organisms have been ob-
served in urine, bile, and duodinal aspirates, as well
as in ocular, sinus, bronchial, renal, hepatic, and
other tissue (5).  E. hellem, which primarily causes
eye infections, has been exclusively found in AIDS
patients.  Ingestion and inhalation of spores have
been suggested as likely modes of transmission for
microsporidia (5,10). Biochemical, immunologic, and
Synopses
Figure 1. Transmission electron micrograph of a host cell
from cell culture parasitized by Encephalitozoon
intestinalis.  Both vegetative forms and spores can be ob-
served inside the parasitophorous vacuole.  Original
magnification, x5,200.
Figure 2. Transmission electron micrograph showing the
coiled tubule within an Encephalitozoon intestinalis spore
from cell culture.  This unique structure is diagnostic of
microsporidial spores.  Original magnification, x28,500.
Figure 3. Transmission electron micrograph of a cell cul-
ture-derived Encephalitozoon intestinalis spore showing
the polar tubule in the process of being extruded.  The
coiled arrangement of the tubule within the spore is
clearly demonstrated.  Original magnification, x39,000.
Figure 4.  Encephalitozoon hellem spore from cell culture
showing the extruded polar tubule stained by indirect fluo-
rescence antibody by using rabbit polyclonal antibody and
FITC-labeled anti-rabbit antibody.  Original magnifica-
tion, x1,000.
molecular studies performed on E. cuniculi isolates
from mice, rabbits, and dogs indicate that the para-
site can be classified into at least three strains (11).
An evaluation of the immunologic and molecular
characteristics of E. cuniculi isolated from humans
and rabbits indicated that the isolates were an iden-
tical strain, thus suggesting that this microsporidion
is a zoonotic parasite (12).
Traditional Diagnostic Methods
Transmission Electron Microscopy
Definitive diagnosis of microsporidial infection
relies on observating microsporidia in biopsy tissue,
bodily fluid specimens (e.g. urine, sinus aspirates,
bile, cerebral spinal fluid), or stool examined
by transmission electron microscopy (TEM).
Microsporidia can be identified to genus or even




tion of biopsy speci-
mens allows diagnosis
of microsporidial infec-
tion  but not genus or
species identification
of the parasites. Tis-







The small size of the or-
ganisms and the lack of a
noticeable tissue inflammatory response make
microsporidia detection difficult (5).  Once again, the
invasive procedure required for obtaining specimens
and the length of time needed for processing them
are major drawbacks.
Diagnosing microsporidial infections by light
microscopy examination of noninvasively acquired
specimens has been a challenge for laboratorians.
Microsporidial spores are not observed in traditional
ova and parasite examinations, and the parasites
are generally overlooked in Gram-stained prepara-
tions of stool samples because their size, shape, and
staining characteristics are similar to those of many
enteric bacteria.  Weber’s modification of the
trichrome stain has allowed more definitive identi-
fication of microsporidia by light microscopy (15).
With this stain, microsporidial spores appear bright
pinkish-red, and most have a distinctive diagonal
or equatorial line that allows microsporidia and bac-
teria to be easily differentiated (Figure 7).  The
Figure 5. Transmission electron micrograph of an
Enterocytozoon bieneusi spore in a stool specimen show-
ing the characteristic arrangement of the polar tubule in
six turns with two tiers.  Original magnification, x28,500.
Figure 6. Transmission electron micrograph of an
Encephalitozoon intestinalis spore from cell culture show-
ing the polar tubule with four to seven coils in single rows,
which is typical of the genus Encephalitozoon.  Original
magnification, x28,500.
Synopses
Table1. Named human microsporidial pathogens and their clinical syndromes
Pleistophora species Myositis
Nosema connori Disseminated infection
N. ocularum Keratitis
Vittaforma corneae Keratitis
Encephalitozoon cuniculi Peritonitis, fulminant hepatitis,
seizures, rhinosinusitis
E. hellem Conjuctivitis, keratoconjunctivitis,
bronchiolitis, pneumonia, rhinosinusitis,
disseminated infection
E. intestinalis Diarrhea, disseminated infection
Enterocytozoon bieneusi Diarrhea, wasting syndrome,
cholecystitis, cholangitis, bronchitis,
pneumonia
Microsporidia genus and species Clinical syndromes
istics.  All stages of the parasite’s life cycle can be
found in infected tissue, but only the spore stage
can be observed in bodily fluids and stool.  The size
and ultrastructure of spores, particularly the con-
figuration of the coiled tubule, distinguish E.
bieneusi from the Encephalitozoon species (Figures
5 and 6).  Limited success was reported when TEM
was used to detect spores in bodily fluids and stool
specimens to avoid obtaining specimens by invasive
procedures (5).  Tissue specimens are required for
speciation within the Encephalitozoon genus
because the meronts and sporonts, nuclear configu-
ration, and location of replication in the host cell
must be carefully studied (7,10).  Problems with  the
use of TEM include its lack of sensitivity when per-
formed on bodily fluids and stool, the require-
ment for invasive procedures to acquire biopsy speci-
mens, and the laborious procedures for specimen
preparation and examination.
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sensitivity and specificity of the modified trichrome
stain have not been well established.  When results
of the modified trichrome stain performed on stool
specimens and a TEM examination of duodenal bi-
opsy specimens from HIV-infected patients were
compared, E. bieneusi spores were detected in stool
specimens in 9 of 9  patients with moderate or abun-
dant parasites in tissue and in 8(57%) of 14 stool
specimens from patients whose tissue contained few
parasites (16).  This illustrates that microsporidial
spores may not be observed in the stool of some in-
fected patients with the modified trichrome stain.
Various chemofluorescent brighteners (such as
calcofluor white and Uvitex 2B) bind to the en-
dospore layer of microsporidia and allow spores to
be detected quickly and easily in smears of speci-
mens examined with a fluroescence microscope (5).
Fluorescein-labeled polyclonal and monoclonal an-
tibodies are being developed for the detection and
speciation of microsporidia (5,17). Didier et al. (17)
recently compared modified trichrome, calcofluor
white, and a fouorescent polyclonal antibody stain
and found that the polyclonal antibody stain
was the least sensitive method for detecting
microsporidia in stool, urine, and duodenal lavage
specimens.  They proposed screening specimens with
calcofluor white and confirming  positive smears by
using a modified trichrome stain.  However, modi-
fied trichrome and calcofluor white stains do not
allow for speciation of microsporidia; therefore, spe-
cies-specific antibodies should be used to provide
definitive identifications. E.intestinalis-specific
monoclonal antibodies have been used in an immu-
nofluorescence assay for detecting spores in urine,
stool, bronchial brush biopsy specimens, bron-
choalvolar lavage fluid, and samples obtained from
nasal swabs (18).  E. bieneusi-specific antibodies may
not be developed until the organism is successfully
cultivated in long-term culture.
Cell Culture
Microsporidia have been isolated from a variety
of specimen types and in a variety of cell lines (5).
E. hellem, E. intestinalis, and Vittaforma corneae
have been isolated from human specimens and
maintained in continuous culture. Recently, E.
bieneusi has been cultivated on a short-term (6
months) basis in vitro (19).  Detecting microsporidia
in infected cell cultures may take 3 to 10 weeks
(19,20).  Isolating microsporidia in cell culture as a
means of diagnosing infection is laborious and
lengthy and is prone to failure with specimens from
nonsterile sites.  Therefore, cell culture is not rec-
ommended as a routine laboratory technique for
diagnosing microsporidiosis.
Serology
Serologic assays used to detect antibodies to
microsporidia in human sera include immunofluo-
rescence, immunoperoxidase, enzyme-linked
immunosorbent assay (ELISA), and Western blot
(21-23).  The sensitivity and specificity of these meth-
ods for detecting antimicrosporidial antibody are not
known because no comparative evaluations have
been published.  Studies have demonstrated in-
creased rates of seropositivity to E. cuniculi in
persons who live in tropical regions and have tropi-
cal diseases (21,24).  Most notable were E. cuniculi
seropositivity rates of 4.7% in patients with malaria
and 9.1% in patients with schistosomiasis (24).  A
study of homosexual men in Sweden found that 10
(33%) of 30 were seropositive for antibodies to
E. cuniculi, and all seropositive patients plus half
of the seronegative patients had sometimes visit-
ed tropical countries (25).  Studies to detect
microsporidial antibodies in HIV-infected and non-
HIV-infected patients have demonstrated that AIDS
patients can mount an immune response to
microsporidial infection; however, serologic meth-
ods are not useful as diagnostic tools because these
studies have found that at least half of the serum
specimens from persons without a history of
microsporidial infection had positive titers (22,23).
Some of the problems with serologic testing include
the poor response to antigen challenge in immuno-
suppressed persons (26), the probability  that
different (both pathogenic and nonpathogenic)
microsporidia contain common cross-reactive anti-
gens (23,26), and the lack of species-specific reagents
in part because E. bieneusi cannot be grown in con-
tinuous culture.
Molecular Techniques
Characterization of the microsporidial genome
has focused on the small subunit ribosomal RNA
Synopses
Figure 7. Spores of Encephalitozoon intestinalis in a stool
specimen stained with modified trichrome stain.  Note
the characteristic equatorial line in one of the spores.
Original magnification, x1,000.Emerging Infectious Diseases Vol. 3, No. 2—July-September 1996
morphology and ultrastructure and were used to
justify the reclassification of Nosema corneum to
Vittaforma corneae (34).  This reclassification was
confirmed by a study of microsporidial phylogeny
based on evaluation of SSU-rRNA gene sequences
that indicated that N. corneum was more closely
related to the insect parasite Endoreticulatus
schubergi than to the other Nosema species (35) (Fig-
ure 8).  Phylogenetic analysis of the sequences of
the SSU-rRNA genes of microsporidia is often in-
consistent with traditional classifications that are
based on morphologic characteristics observed by
TEM; this was demonstrated by the use of recent
sequence data to determine the correct taxonomic
placement of E. intestinalis (32,35).  This organism
was named Septata intestinalis because unique
septations between spores within the parasit-
ophorous vacuole were observable by TEM (36).
Although the various stages of the microorganism
throughout its life cycle are indistinguishable from
those of E. cuniculi, the observation of septations
Synopses
(SSU-rRNA) gene.  The sequence of the SSU-rRNA
gene of the microsporidium Vairimorpha necatrix
was published by Vossbrinck et al. in 1987 (27).  The
V. necatrix SSU-rRNA gene was far shorter than a
typical eukaryotic SSU-rRNA gene and lacked sev-
eral universal (and eukaryotic-specific) sequences.
PCR amplification with primers complementary
with conserved sequences of the V. necatrix SSU-
rRNA gene has been used to generate sequence
information from microsporidia that infect humans.
SSU-rRNA gene sequences have been published for
E. cuniculi (28,29,30,31), E. hellem (30,31), E.
intestinalis (31,32), and E. bieneusi (31,33), and an
unpublished sequence for V. corneae has been
deposited into GenBank National Center for Bio-
technology Information, National Institutes of
Health, accession 0.5 U11046.
Taxonomic decisions concerning the micro-
sporidia have been based historically on morphologic
characteristics as established by TEM.  These crite-
ria are still valid for organisms with unique
Figure 8. Cladogram representing the phylogenic relationship of several microsporidial genera as determined by small
subunit ribosomal DNA sequence similarity.  The human pathogens can be found in the Encephalitozoon group and the
Endoreticulatus group. (Reprinted with permission from ref. 35.)188 Emerging Infectious Diseases Vol. 2, No. 3—July-September 1996
allowed  the organism to be identified.  The E.
intestinalis SSU-rRNA gene contained sufficient
unique sequences to establish this organism as an
independent species but shared about 90% se-
quence homology with the other two characterized
Encephalitozoon species, E. cuniculi and E. hellem.
Molecular techniques have confirmed the exist-
ence of different strains of E. cuniculi that have been
isolated from mice, rabbits, and dogs (11).  Three
antigenically different strains were detected by
sodium dodecyl sulfate-polyacrylamide gel (SDS-
PAGE) and Western blot.  Double-stranded DNA
heteroduplex mobility, restriction fragment length
polymorphism with the restriction endonuclease Fok
I, and DNA sequencing were performed on the PCR
products generated by using a set of primers to am-
plify the entire microsporidial SSU-rRNA gene and
a second set of primers specific for Encephalitozoon
species.  These methods allowed three strains of E.
cuniculi  to be clearly separated.  The existence of
different strains of E. bieneusi was suggested after
SSU-rRNA gene sequences of organisms from max-
illary sinus mucosa had been compared with those
from intestinal enterocytes (37).  Sequencing errors
in this study were minimized by analyzing multiple
recombinant DNA clones.  SSU-rRNA sequences
from E. bieneusi and Encephalitozoon species de-
rived from a variety of clinical specimens must be
compared to establish the existence of intraspecific
genetic variation in these organisms.
Molecular Diagnosis
Primer pairs that amplify the entire micro-
sporidial SSU-rRNA gene sequence produce
amplicons of approximately 1,550 base pairs in
length from Encephalitozoon species and E. bieneusi
(28,33).  Although these primer pairs have proven
useful for sequencing and taxonomic studies, the tar-
gets are too long to be efficiently amplified from
clinical specimens in a diagnostic assay.  Targets for
diagnostic PCR that can be amplified efficiently usu-
ally range from 100 to 400 base pairs for
formalin-fixed tissue or up to 700 to 1,000 base pairs
in fresh specimens (38).  Several primer pairs de-
signed to amplify short regions (250 to 607 base
pairs) of the SSU-rRNA gene, and their application
in the diagnosis of microsporidial infection by PCR
have been published (Table 2).  Primers specific for
E. hellem and E. cuniculi-specific- primers have been
used to identify microsporidia cultured from patient
specimens (39,40), but only E. bieneusi and E.
intestinalis SSU-rRNA DNA have been amplified
directly from patient specimens (31,33,41,42).  A pair
of  E. bieneusi-specific primers amplified cloned E.
bieneusi SSU-rRNA gene sequences but did not re-
liably amplify DNA from infected tissue (33).  Not
unexpectedly, therefore, some primer sets appear to
be adequate for amplification from cultured organ-
isms or cloned sequences but may not reliably
amplify microsporidial DNA in patient specimens.
The primer pair V1 and EB450 (Table 2) amplifies
Synopses
Table 2. SSU-rRNA PCR primer pairs for the diagnosis of microsporidial infection
Primer pair (no. nucleotides) Primer Organisms Amplicon size Source References
designation amplified in base pairs of Target
5'-CACCAGGTTGATTCTGCCTGAC-3' (22) V1 Enterocytozoon 348 Biopsied tissue 33, 41
bieneusi Duodenal aspirates 31 5'-ACTCAGGTGTTATACTCACGTC-3' (22) EB450 Encephalitozoon Cultured organisms 33
hellem
5'-GAAACTTGTCCACTCCTTACG-3' (21) EBIEF1 E.bieneusi 607 Bile 43
5'-CCATGCACCACTCCTGCCATT-3' (21) EBIER1 Duodenal aspirates
5'-TGAGAAGTAAGATGTTTAGCA-3' (21) E.hellem 547 Cultured organisms 39
5'-GTAAAAACACTCTCACACTCA-3' (21)
5'-ATGAGAAGTGATGTGTGTGCG-3' (21) Encephalitozoon 549 Cultured organisms 39, 40
5'-TGCCATGCACTCACAGGCATC-3' (21) cuniculi
5'-CACCAGGTTGATTCTGCCTGAC-3' (22) V1 Encephalitozoon 370 Biopsied tissue 31
5'-CTCGCTCCTTTACACTCGAA-3' (20) SI500 intestinalis
5'-CACCAGGTTGATTCTGCCTGAC-3' (22) PMP1* E.bieneusi 250 Stool 42
5'-CCTCTCCGGAACCAAACCTG-3' (21) PMP2 E.cuniculli 268 Cultured organisms
E.intestinalis 270 Stool
E.hellem 279 Cultured organisms
*The nucleotide sequence of primer PMP1 is identical to that of primer V1.Vol. 2, No. 3—July-September 1996 Emerging Infectious Diseases 189
E. bieneusi from TEM- confirmed infected tissue and
E. hellem from cell culture (33).  This primer pair
has not, however, been evaluated for its ability to
amplify E. hellem from patient specimens.  Primer
pair V1 and EB450 was extensively tested by da
Silva, et al. (43), who found that the primer pair did
amplify  E. bieneusi DNA from some patient speci-
mens that had evidence of the parasite by electron
microscopy.  In addition, the primer pair did not
amplify DNA of E. bieneusi derived from a short-
term culture.  da Silva et al. (43) described a pair of
highly specific PCR primers for amplifing E.
bieneusi; these are called EBIEF1 and EBIER1
(Table 2), and are based on SSU-rRNA sequences
they generated.  This primer pair amplified E.
bieneusi DNA from cultured organisms, cloned re-
gions of the SSU-rRNA, and patient specimens, but
did not amplify SSU-rRNA-coding regions of 13 other
genera and species of microsporidia.  The primer pair
V1 and SI500 amplifies E. intestinalis from intesti-
nal biopsy material confirmed by TEM as infected,
but does not simplify  E. bieneusi-infected tissue
samples or E. cuniculi from cell culture (31).  This
primer pair has not been evaluated for its ability to
amplify other microsporidia.
To avoid acquiring specimens by invasive proce-
dures, PCR was used to detect microsporidia in stool
specimens (42).  Primer pair PMP1 and PMP2 (Table
2) allows E. bieneusi and the Encephalitozoon spe-
cies (42) to be amplified and will also amplify V.
corneae from culture (D.P. Fedorko, unpublished
data).  DNA is easily extracted from cultured organ-
isms and biopsied tissue specimens, but extracting
DNA from spores requires harsh conditions employ-
ing both mechanical and chemical disruption.  A
major problem with performing PCR on stool speci-
mens is the presence of PCR inhibitors.  Treating
the stool specimens with sodium hypochlorite or 10%
formalin before DNA extraction inactivates micro-
organisms in the stool and has the beneficial effect
of inactivating Taq polymerase inhibitors.
Both DNA probes and restriction enzyme diges-
tion have been used to confirm the identity of
PCR amplicons (33,41,42). An internal 30 meroli-
gonucleotideEB150 (5'TGTTGCGGTAATTTG-
GTCTCTGTGTGTAAA-3'), complementary to a re-
gion of the amplicon produced by primer pair V1
and EB450, has been used to detect E. bieneusi by
Southern blot (31,41).  Probe EB150 has been re-
ported, however, to hybridize with E. hellem,
amplified by V1 and EB450, albeit at a lower inten-
sity than E. bieneusi (31).  PCR products amplified
from stool specimens by using primers PMP1 and
PMP2 have been digested with restriction endonu-
cleases  HaeIII and PstI to distinguish between
infection with E. bieneusi and E. intestinalis (42).
These restriction enzymes do not allow E. in-
testinalis to be differentiated from E. cuniculi, thus
limiting their use to diagnosing gastrointestinal in-
fection.
An efficient approach for the molecular detection
of microsporidia in patient specimens would involve
using universal or “pan-microsporidian” primers for
amplification.  The species of microsporidia detected
could be determined by using restriction endonu-
clease digestion or DNA probe assays of the
amplified DNA or repeat PCR with species-specific
primers.  Negative specimens would require no fur-
ther evaluation.  Primers PMP1 and PMP2 appear
to be panmicrosporidian (42), but this primer pair
needs to be evaluated for its ability to amplify
microsporidian DNA from a wide range of clinical
specimens.  Didier et al. (44) have used pan-
Encephalitozoon primers that amplified a product
approximately 1,000 base pairs in length, which in-
cluded a  large portion of the SSU-rRNA gene and a
small portion of the large subunit rRNA gene.  They
successfully amplified E. hellem DNA from urine and
conjunctival specimens from a patient with AIDS.
Southern blotting and a species-specific probe were
used to identify the organism to species.
The application of molecular diagnostic tech-
niques for microsporidiosis is in its infancy.  There
have been no published reports of comparisons of
PCR to other methods to determine sensitivity and
specificity.  Careful selection of primers and probes
coupled with highly stringent conditions will be re-
quired to detect and speciate microsporidia in patient
specimens.  The potential for PCR to identify spe-
cies of microsporidia from non-invasively acquired
specimens makes this technique an extremely at-
tractive diagnostic option.  Although PCR can be
used for detection and speciation of microsporidia
in patient specimens, screening for microsporidia by
using chemofluorescent stains and modified
trichrome stains followed by confirmation and spe-
ciation with PCR may become the paradigm for the
laboratory diagnosis of microsporidiosis.
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